CompoAtlas

Drépanyl Plus

Food supplement declared in France, declaration No 2024-2-405, decision dated 8 February 2024

Drépanyl Plus (TITIS) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 point in its composition requires a check (prohibited substance, dose or novel food).

Brand
TITIS
Food business operator placing the product on the market
LABORATOIRES TBC TITIS
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
2 gélules
Directions for use
1 gélules par prise, le matin et le soir
Not recommended for (according to the manufacturer)
Femmes allaitantes, Femmes enceintes, Problèmes cardiaques, Problèmes de foie, Sous anticoagulants, Sous antidiabétiques, Enfants (de moins de 6 ans)
Objectives stated by the manufacturer (these are not authorised claims)
Articulations, Circulation sanguine et lymphatique, Immunité

Declaration 309506, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Zanthoxylum americanum Mill.EcorceExtrait sec aqueux500 mg
Berberis vulgaris L.RacineExtrait sec aqueux380 mg

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Pyridoxine 5'-phosphateVitamine B612 mg2 mg
Gluconate de zincZinc25 mg15 mg

Other ingredients

farine de riz

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2024. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

Label warnings

Personnes ayant des troubles hépatiques et cardiaques. L'emploi chez les personnes souffrant de pathologies de voies biliaires est déconseillé.Les personnes sous traitement médicaux doivent consulter un professionnel de la santé.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : TITIS

List recorded in 2024. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line